Disappointment! Shareholders again let down. Yet another inadequate more of the same secretive 4C; just enough carrot there for the loyalists to again spruke that the next 4C should be the sp turning point so ‘watch this space’.
Midkine kicked down the road, for what is it.....the 40th 4C , with again nothing of substance in this 4C. who knows what’s going on there and if anything positive will ever emerge.
Many invested in CDY on Mikine’s prospects. A lot of posters’ time and energy has been spent over the decade on trying to join the Midkine dots. The posts have given us 100 fold the scant info from CDY, yet we still have nothing of substance to make informed investment decisions (even though still speculative). Why is there again no indication of progress, let alone any detail, on anything Midkine? It can’t all be hidden under commercial-in-confidence.
No sales figures or other helpful info on the woeful underperformance in Australia, only an apology of sorts that they plan to do better in Oz one day; how many pharmacies in Oz are selling Evolis for what quarterly sales? Is the average monthly sales per pharmacy pathetically <$40? Who/how services the pharmacies?
No detail on progress to Color Collective’s $100m US sales within 7 years, and no segmented sales details;
No direct guidance going forward other than a snippet about product packaging bottles.
CDY Price at posting:
27.5¢ Sentiment: Hold Disclosure: Held
